Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

GLOFIL-125

IOTHALAMATE SODIUM I-125

Standard Dose
250-300uCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GLOFIL-125 is listed in Drugs@FDA under application 017279 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IOTHALAMATE SODIUM I-125 Form and strength INJECTABLE;INJECTION - 250-300uCi/ML Sponsor ISOTEX Submission history Latest submission status date: 2002-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLOFIL-125 is listed in Drugs@FDA under application 017279 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IOTHALAMATE SODIUM I-125 Form and strength INJECTABLE;INJECTION - 250-300uCi/ML Sponsor ISOTEX Submission history Latest submission status date: 2002-01-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
GLOFIL-125 (IOTHALAMATE SODIUM I-125) | Drug Monograph | MedicHelpline